BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33383437)

  • 1. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
    Arumugam P; George R; Jayaseelan VP
    Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
    Paramasivam A; George R; Priyadharsini JV
    Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
    Ban Y; Tan P; Cai J; Li J; Hu M; Zhou Y; Mei Y; Tan Y; Li X; Zeng Z; Xiong W; Li G; Li X; Yi M; Xiang B
    Mol Oncol; 2020 Jun; 14(6):1282-1296. PubMed ID: 32216017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The m
    Romanowska K; Rawłuszko-Wieczorek AA; Marczak Ł; Kosińska A; Suchorska WM; Golusiński W
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma.
    Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L
    BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The m6A readers
    Anita R; Paramasivam A; Priyadharsini JV; Chitra S
    Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of m6A-related LncRNAs in patients with HNSCC: bioinformatics analysis of TCGA database.
    Zhou LQ; Shen JX; Zhou JY; Hu Y; Xiao HJ
    Sci Rep; 2022 Jan; 12(1):579. PubMed ID: 35022464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.
    Chen X; Fan R
    J Oral Pathol Med; 2024 Apr; 53(4):266-274. PubMed ID: 38531807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
    Hu Y; Chen J; Liu M; Feng Q; Peng H
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Investigation of m6A Regulators for Prognosis in Head and Neck Squamous Cell Carcinoma.
    Cheng J; Lyu Y; Cheng Z
    J Environ Pathol Toxicol Oncol; 2024; 43(1):45-60. PubMed ID: 37824369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
    Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
    Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
    Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
    Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
    Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
    Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
    Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.